An interferon inducing porcine reproductive and respiratory syndrome virus vaccine candidate elicits protection against challenge with the heterologous virulent type 2 strain VR-2385 in pigs

Vaccine

Volumn 35, Issue 1, 2017, Pages 125-131

  Fontanella, Eve ^a   Ma, Zexu ^b   Zhang, Yanjin ^b   de Castro, Alessandra M M G ^a   Shen, Huigang ^a   Halbur, Patrick G ^a   Opriessnig, Tanja ^a,c  

^a IOWA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Efficacy; Porcine reproductive and respiratory syndrome virus; PRRSV; Vaccine

Indexed keywords

NEUTRALIZING ANTIBODY; PORCINE REPRODUCTIVE AND RESPIRATORY VIRUS VACCINE; UNCLASSIFIED DRUG; VIRUS RNA; VIRUS VACCINE; INTERFERON; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; NONHUMAN; PIG; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS; PRIORITY JOURNAL; VACCINATION; VIRUS STRAIN; ANIMAL; ANTIBODY PRODUCTION; BLOOD; BODY WEIGHT; IMMUNOLOGY; LUNG; PATHOLOGY; RANDOMIZATION; SECRETION (PROCESS); TREATMENT OUTCOME; VIREMIA; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY FORMATION; BODY WEIGHT; INTERFERONS; LUNG; PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; RANDOM ALLOCATION; SWINE; TREATMENT OUTCOME; VIRAL VACCINES; VIREMIA; VIRUS SHEDDING;

EID: 84999802764     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2016.11.020     Document Type: Article

References (31)

1. [1] Holtkamp, D.J., Kliebenstein, J.B., Neumann, E.J., et al. Assessment of the economic impact of porcine reproductive and respiratory syndrome virus on United States pork producers. J Swine Health Prod 21:2 (2013), 72–84.
2. [2] Meulenberg, J.J., Hulst, M.M., de Meijer, E.J., et al. Lelystad virus belongs to a new virus family, comprising lactate dehydrogenase-elevating virus, equine arteritis virus, and simian hemorrhagic fever virus. Arch Virol 9 (1994), 441–448.
3. [3] Cavanagh, D., Nidovirales: a new order comprising Coronaviridae and Arteriviridae. Arch Virol 142:3 (1997), 629–633.
4. [4] Benfield, D.A., Nelson, E., Collins, J.E., et al. Characterization of swine infertility and respiratory syndrome (SIRS) virus (isolate ATCC VR-2332). J Vet Diagn Invest 4:2 (1992 Apr), 127–133.
5. [5] Nelsen, C.J., Murtaugh, M.P., Faaberg, K.S., Porcine reproductive and respiratory syndrome virus comparison: divergent evolution on two continents. J Virol 73:1 (1999 Jan), 270–280.
6. [6] Wensvoort, G., Terpstra, C., Pol, J.M., et al. Mystery swine disease in The Netherlands: the isolation of Lelystad virus. Vet Q 13:3 (1991 Jul), 121–130.
7. [7] Le, G.A., Legeay, O., Bourhy, H., Arnauld, C., Albina, E., Jestin, A., Molecular variation in the nucleoprotein gene (ORF7) of the porcine reproductive and respiratory syndrome virus (PRRSV). Virus Res 54:1 (1998 Mar), 9–21.
8. [8] Shi, M., Lam, T.T., Hon, C.C., et al. Molecular epidemiology of PRRSV: a phylogenetic perspective. Virus Res 154:1–2 (2010 Dec), 7–17.
9. [9] Rowland, R.R., Steffen, M., Ackerman, T., Benfield, D.A., The evolution of porcine reproductive and respiratory syndrome virus: quasispecies and emergence of a virus subpopulation during infection of pigs with VR-2332. Virology 259:2 (1999 Jul 5), 262–266.
10. [10] Goldberg, T.L., Lowe, J.F., Milburn, S.M., Firkins, L.D., Quasispecies variation of porcine reproductive and respiratory syndrome virus during natural infection. Virology 317:2 (2003 Dec 20), 197–207.
11. [11] Renukaradhya, G.J., Meng, X.J., Calvert, J.G., Roof, M., Lager, K.M., Live porcine reproductive and respiratory syndrome virus vaccines: current status and future direction. Vaccine 33:33 (2015 Aug 7), 4069–4080.
12. [12] Botner, A., Strandbygaard, B., Sorensen, K.J., et al. Appearance of acute PRRS-like symptoms in sow herds after vaccination with a modified live PRRS vaccine. Vet Rec 141:19 (1997 Nov 8), 497–499.
13. [13] Opriessnig, T., Halbur, P.G., Yoon, K.J., et al. Comparison of molecular and biological characteristics of a modified live porcine reproductive and respiratory syndrome virus (PRRSV) vaccine (ingelvac PRRS MLV), the parent strain of the vaccine (ATCC VR2332), ATCC VR2385, and two recent field isolates of PRRSV. J Virol 76:23 (2002 Dec), 11837–11844.
14. [14] Nan, Y., Wang, R., Shen, M., Faaberg, K.S., Samal, S.K., Zhang, Y.J., Induction of type I interferons by a novel porcine reproductive and respiratory syndrome virus isolate. Virology 432:2 (2012 Oct 25), 261–270.
15. [15] Wang, R., Xiao, Y., Opriessnig, T., et al. Enhancing neutralizing antibody production by an interferon-inducing porcine reproductive and respiratory syndrome virus strain. Vaccine 31:47 (2013 Nov 12), 5537–5543.
16. [16] Ma, Z., Yu, Y., Xiao, Y., et al. Sustaining interferon induction by a high-passage atypical porcine reproductive and respiratory syndrome virus strain. Sci Rep, 6, 2016, 36312.
17. [17] Halbur, P.G., Paul, P.S., Frey, M.L., et al. Comparison of the pathogenicity of two US porcine reproductive and respiratory syndrome virus isolates with that of the Lelystad virus. Vet Pathol 32:6 (1995 Nov), 648–660.
18. [18] Gerber, P.F., O'Neill, K., Owolodun, O., et al. Comparison of commercial real-time reverse transcription-PCR assays for reliable, early, and rapid detection of heterologous strains of porcine reproductive and respiratory syndrome virus in experimentally infected or noninfected boars by use of different sample types. J Clin Microbiol 51:2 (2013 Feb), 547–556.
19. [19] Halbur, P.G., Andrews, J.J., Huffman, E.L., Paul, P.S., Meng, X.J., Niyo, Y., Development of a streptavidin-biotin immunoperoxidase procedure for the detection of porcine reproductive and respiratory syndrome virus antigen in porcine lung. J Vet Diagn Invest 6:2 (1994 Apr), 254–257.
20. [20] Albina, E., Carrat, C., Charley, B., Interferon-alpha response to swine arterivirus (PoAV), the porcine reproductive and respiratory syndrome virus. J Interferon Cytokine Res 18:7 (1998 Jul), 485–490.
21. [21] Buddaert, W., Van, R.K., Pensaert, M., In vivo and in vitro interferon (IFN) studies with the porcine reproductive and respiratory syndrome virus (PRRSV). Adv Exp Med Biol 440 (1998), 461–467.
22. [22] Takaoka, A., Yanai, H., Interferon signalling network in innate defence. Cell Microbiol 8:6 (2006 Jun), 907–922.
23. [23] González-Navajas, J.M., Lee, J., David, M., Raz, E., Immunomodulatory functions of type I interferons. Nat Rev Immunol 12:2 (2012 Jan 6), 125–135.
24. [24] Gauger, P.C., Faaberg, K.S., Guo, B., Kappes, M.A., Opriessnig, T., Genetic and phenotypic characterization of a 2006 United States porcine reproductive and respiratory virus isolate associated with high morbidity and mortality in the field. Virus Res 163:1 (2012 Jan), 98–107.
25. [25] Cho, J.G., Deen, J., Dee, S.A., Influence of isolate pathogenicity on the aerosol transmission of Porcine reproductive and respiratory syndrome virus. Can J Vet Res 71:1 (2007 Jan), 23–27.
26. [26] Faaberg, K.S., Hocker, J.D., Erdman, M.M., et al. Neutralizing antibody responses of pigs infected with natural GP5 N-glycan mutants of porcine reproductive and respiratory syndrome virus. Viral Immunol 19:2 (2006), 294–304.
27. [27] Nilubol, D., Platt, K.B., Halbur, P.G., Torremorell, M., Harris, D.L., The effect of a killed porcine reproductive and respiratory syndrome virus (PRRSV) vaccine treatment on virus shedding in previously PRRSV infected pigs. Vet Microbiol 102:1–2 (2004 Aug 19), 11–18.
28. [28] Cutler, T.D., Wang, C., Hoff, S.J., Kittawornrat, A., Zimmerman, J.J., Median infectious dose (ID(5)(0)) of porcine reproductive and respiratory syndrome virus isolate MN-184 via aerosol exposure. Vet Microbiol 151:3–4 (2011 Aug 5), 229–237.
29. [29] Frydas, I.S., Verbeeck, M., Cao, J., Nauwynck, H.J., Replication characteristics of porcine reproductive and respiratory syndrome virus (PRRSV) European subtype 1 (Lelystad) and subtype 3 (Lena) strains in nasal mucosa and cells of the monocytic lineage: indications for the use of new receptors of PRRSV (Lena). Vet Res, 44, 2013, 73.
30. [30] Ellingson, J.S., Wang, Y., Layton, S., Ciacci-Zanella, J., Roof, M.B., Faaberg, K.S., Vaccine efficacy of porcine reproductive and respiratory syndrome virus chimeras. Vaccine 28:14 (2010 Mar 19), 2679–2686.
31. [31] Yoon, K.J., Zimmerman, J.J., Chang, C.C., Cancel-Tirado, S., Harmon, K.M., McGinley, M.J., Effect of challenge dose and route on porcine reproductive and respiratory syndrome virus (PRRSV) infection in young swine. Vet Res 30:6 (1999 Nov), 629–638.